This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Mar 1;543(7643):40.

doi: 10.1038/543040d.

Preclinical data: Three-point plan for reproducibility

E Andrew Balas¹, Lee M Ellis²

Affiliations

PMID: 28252077
DOI: 10.1038/543040d

Comment

Preclinical data: Three-point plan for reproducibility

E Andrew Balas et al. Nature. 2017.

. 2017 Mar 1;543(7643):40.

doi: 10.1038/543040d.

Authors

E Andrew Balas¹, Lee M Ellis²

Affiliations

¹ Augusta University, Georgia, USA.
² University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

PMID: 28252077
DOI: 10.1038/543040d

No abstract available

PubMed Disclaimer

Comment on

Consider drug efficacy before first-in-human trials.
Kimmelman J, Federico C. Kimmelman J, et al. Nature. 2017 Jan 30;542(7639):25-27. doi: 10.1038/542025a. Nature. 2017. PMID: 28150789 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations